Infectious mononucleosis and Epstein-Barr virus. 2. Clinical picture, diagnosis, management.
The diagnosis of infectious mononucleosis is confirmed by hematologic, biochemical, and serologic data. An absolute increase in peripheral mononuclear cells to at least 4,500/cu mm is an essential feature. The serologic hallmark of the disease is the presence of heterophile antibody. The age of the patient may affect the clinical presentation and laboratory findings. Therapy is largely supportive, with steroids being used only in the presence of certain severe complications.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000910:Antibodies, Heterophile / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D002467:Cell Nucleus; D002648:Child; D003937:Diagnosis, Differential; D004854:Herpesvirus 4, Human; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D007158:Immunologic Techniques; D007244:Infectious Mononucleosis / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D008214:Lymphocytes; D008875:Middle Aged; D011379:Prognosis; D012146:Rest; D013256:Steroids / Q000627:therapeutic use
D000910:Antibodies, Heterophile; D007075:Immunoglobulin M; D013256:Steroids; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase